BERWYN, Pa., Feb. 11, 2021 /PRNewswire/ — AMETEK, Inc. (NYSE: AME) these days introduced that its Board of Administrators has appointed Karleen Oberton as a new director of the Company. Ms. Oberton serves as Main Monetary Officer of Hologic, Inc. (NASDAQ: HOLX), an progressive health-related technological innovation corporation generally centered on strengthening women’s wellness and nicely-being via early detection and remedy units.
“We are happy to welcome Karleen to AMETEK as a member of our Board of Directors,” commented David A. Zapico, AMETEK Chairman and Chief Government Officer. “Karleen is a skilled business executive with more than 30 years of encounter in general public accounting, biotechnology and healthcare gadget production. Her powerful monetary acumen together with her proven govt leadership taking care of international corporations nicely enhances our current Board talent set.”
Becoming a member of Hologic as Vice President and Company Controller in 2006, Ms. Oberton has because held roles of raising responsibility inside the company’s finance operate. In 2014, she was named Company Vice President and Main Accounting Officer and in 2018 was elected Chief Economic Officer. Prior to becoming a member of Hologic, Ms. Oberton served as Senior Corporate Controller for ImmunoGen, a biotechnology corporation creating targeted anticancer therapeutics. Earlier in her occupation, Ms. Oberton held management positions at Ernst & Younger and Arthur Andersen.
Ms. Oberton retains a bachelor’s diploma in Organization Administration from Merrimack College or university and was an lively Qualified General public Accountant for far more than 18 several years.
AMETEK is a top world wide producer of digital devices and electromechanical gadgets with 2020 gross sales of far more than $4.5 billion. The AMETEK Advancement Product integrates the 4 Expansion Approaches – Operational Excellence, New Product Progress, Worldwide and Current market Enlargement, and Strategic Acquisitions – with a disciplined focus on dollars era and capital deployment. AMETEK’s goal is double-digit proportion expansion in earnings for every share above the company cycle and a superior return on overall money. The typical stock of AMETEK is a part of the S&P 500.
Vice President, Investor Relations
1100 Cassatt Highway
Berwyn, Pennsylvania 19312
Supply AMETEK, Inc.